BioLife Solns (NASDAQ:BLFS) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.04) by 124.32 percent. This is a 118 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $25.421 million which beat the analyst consensus estimate of $23.710 million by 7.21 percent. This is a 10.26 percent decrease over sales of $28.328 million the same period last year.